J. L. Bainbridge & Co., Inc. Gilead Sciences, Inc. Call Options Transaction History

J. L. Bainbridge & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $1.15 Million - $1.3 Million	-20,000 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $648,800 - $736,400	-10,000 Reduced 33.33%	20,000 $1.45 Million
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $1.13 Million - $1.29 Million	20,000 Added 200.0%	30,000 $1.75 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $289,360 - $336,000	4,000 Added 66.67%	10,000 $769,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $369,720 - $406,680	6,000 New	6,000 $390,000

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.